A 48-year-old man from Mumbai presents with acute onset of severe pain, swelling, and warmth in his right calf for 2 days. He returned from a 6-hour flight 3 days ago. On examination, his right calf circumference is 3 cm larger than the left, with pitting edema and positive Homan's sign. D-dimer is elevated at 2.8 μg/mL (normal <0.5). Duplex ultrasonography shows non-compressible thrombus in the right popliteal vein extending into the distal femoral vein. He is hemodynamically stable with normal oxygen saturation. What is the most appropriate initial management?

Explanation

## Clinical Diagnosis: Acute Deep Vein Thrombosis **Key Point:** This patient has **acute proximal DVT** (popliteal + distal femoral vein involvement) confirmed on duplex ultrasonography. Risk factors include recent air travel (immobilization), and presentation is within the acute window (2 days). ## Diagnostic Confirmation | Feature | Finding | Significance | |---------|---------|---------------| | **Onset** | 2 days (acute) | Within thrombolytic window | | **Risk factor** | 6-hour flight | Immobilization-induced thrombosis | | **Duplex** | Non-compressible thrombus in popliteal + distal femoral vein | Proximal DVT (high risk for PE) | | **D-dimer** | Elevated 2.8 μg/mL | Confirms thrombotic state | | **Hemodynamics** | Stable, normal SpO₂ | No acute PE at presentation | ## Immediate Management: Anticoagulation **High-Yield:** First-line treatment for acute DVT is **anticoagulation** — either: 1. **Unfractionated heparin (UFH)** — preferred if thrombolysis is being considered (shorter half-life, reversible) 2. **Low-molecular-weight heparin (LMWH)** — if thrombolysis not planned 3. **Fondaparinux** — alternative if HIT history **Clinical Pearl:** UFH is preferred in this case because: - Acute proximal DVT with recent onset (within 2 weeks) is a **candidate for catheter-directed thrombolysis (CDT)** - CDT can reduce post-thrombotic syndrome risk if performed within 14 days - UFH has shorter half-life, allowing rapid reversal if bleeding occurs during thrombolysis ## Rationale for Thrombolysis Consideration **Mnemonic: ACUTE DVT THROMBOLYSIS CRITERIA — PROXIMAL LIMB** - **P**roximal DVT (popliteal, femoral, iliac) ✓ - **R**ecent onset (<14 days) ✓ - **O**utcome: reduces post-thrombotic syndrome - **X**ial (extensive) thrombus burden ✓ - **I**lio-femoral or popliteal involvement ✓ - **M**uscle viability preserved ✓ - **A**cute presentation ✓ - **L**ow bleeding risk (stable, no contraindications) ✓ **Key Point:** Catheter-directed thrombolysis is increasingly used for proximal DVT in acute presentation to reduce post-thrombotic syndrome (chronic pain, swelling, ulceration) [cite:Rutherford 8e Ch 26]. ## Why Not IVC Filter Alone? **Warning:** IVC filter placement WITHOUT anticoagulation is contraindicated in acute DVT because: - Filters prevent PE but do NOT treat the underlying thrombosis - Thrombus continues to propagate and organize - Risk of filter thrombosis and recurrent DVT - Reserved for patients with **contraindications to anticoagulation** (active bleeding, severe thrombocytopenia) - This patient has NO contraindication to anticoagulation ## Why Not Observation or Antiplatelet Therapy? - **Observation alone** is dangerous — untreated proximal DVT has ~50% risk of PE - **Aspirin** is inadequate for acute DVT — anticoagulation (not antiplatelet) is required - Both delay definitive treatment and increase thromboembolic risk ## Subsequent Management 1. **Anticoagulation:** UFH bolus 80 U/kg IV, then 18 U/kg/hr infusion (target aPTT 1.5–2.5× control) 2. **Thrombolysis:** Consider CDT within 14-day window (reduces post-thrombotic syndrome) 3. **Transition:** After 5–7 days of parenteral anticoagulation, transition to: - DOAC (apixaban, rivaroxaban) — preferred for provoked DVT - Or warfarin (INR 2–3) if DOAC contraindicated 4. **Duration:** 3 months for provoked DVT (flight-related immobilization) [cite:ACCP Guidelines 10e]